Thrombosis
News
Study supports immediate compression after DVT
Immediate compression therapy provides a “clear benefit” for patients with deep vein thrombosis (DVT), according to the senior author of a study...
From the Journals
Coagulopathy outbreak underscores danger of synthetic cannabinoids
Four patients died after developing spontaneous intracranial bleeding.
News
Product approved to treat hemophilia A in Japan
The Japanese Ministry of Health, Labour and Welfare has approved Jivi® (also known as damoctocog alfa pegol or antihemophilic factor [recombinant...
News
CHMP recommends factor VIII therapy for hemophilia A
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for damoctocog alfa pegol, a...
Conference Coverage
Drug-coated stent bests bare metal in patients with high bleeding risk
SAN DIEGO – Positive
Conference Coverage
Rivaroxaban bonus: Early unmasking of occult GI cancers
MUNICH – Secondary analysis of COMPASS trial hits pay dirt.
News
EC approves product for von Willebrand disease
The European Commission (EC) has granted marketing authorization for vonicog alfa (Veyvondi), a recombinant von Willebrand factor (rVWF) product...
Conference Coverage
Think DEB, not BMS, with high bleeding risk
PARIS – Potentially practice-changing results of DEBUT trial.
Guidelines
New stroke intervention guidelines stress volume
News
Hemophilia B drug available in larger vial
CSL Behring has announced that Idelvion (Coagulation Factor IX [Recombinant], Albumin Fusion Protein) is now available in a 3500 IU vial size....
News
Caplacizumab approved to treat aTTP
The European Commission has granted marketing authorization for caplacizumab (Cablivi™), a humanized bivalent nanobody that inhibits the...